| 摘要 |
The present invention is directed to method of identifying risk of developing obesity, the metabolic syndrome and type 2 diabetes in a human individual, the method comprising: determining the presence or absence or the degree of heteroplasmy of mutations and other variants in the individual's mitochondrial DNA related to the risk of obesity, the metabolic syndrome and/or type 2 diabetes and determining the overall mutation level of the mitochondrial genome of said individual. |
